Allied Market Research


Intravenous Ibuprofen Professional Market

Intravenous Ibuprofen Professional Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Application, by Age Group and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Acute pain is a rising concern among patients suffering from chronic diseases such as cardiovascular syndromes and arthritis. It outlines the occurrence of tissue damage. Pain tends to activate central nervous system and increases the blood pressure and respiratory rate. Treatment of acute pain disorders is carried out with the help of opioid analgesics, as they are useful in mitigating pain. In addition, intravenous ibuprofen is administered during respiratory and orthopedic surgery as well as to treat abdominal syndromes. It is majorly administered as an injectable also known as nonsteroid anti-inflammatory drug (NSAID). Additionally, precautions have to be followed in case the drug is administered to patients suffering from respiratory disorders such as bronchial asthma, chronic rhinitis, and gastrointestinal bleeding. Few of the side effects associated with overdose include nausea, vomiting, headache, and gastric unbalance.

Based on age group, intravenous ibuprofen can be administered to both pediatrics and adults, with geriatric adults dominating the market, owing to rise in prevalence of chronic diseases such as cardiovascular disorders, heart failures around the globe, and subsequent increase in demand for advanced therapeutic drugs. Furthermore, based on end user, hospitals and ambulatory surgical centers dominate the market, owing to highest number of doses of intravenous ibuprofen that are administered in hospitals and ambulatory surgical centers.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the intravenous ibuprofen professional market.

Top Impacting Factors

  • Increasing prevalence of chronic diseases being witnessed around the globe and resulting rise in the demand for advanced therapeutic to cure associated side effects and pain is driving the growth for intravenous ibuprofen.
  • General rise in the number of surgeries being carried out around the globe coupled with rising awareness about advanced therapeutic drugs associated with operative and post-operative pain and rising disposable income in industrialized economies drive market growth for intravenous ibuprofen.
  • Additionally, increasing private sector investments being inflexed into healthcare and medical infrastructure especially due to COVID-19 scenario is bound to boost growth of the intravenous ibuprofen market.
  • Moreover, as the demand for opioid analgesics decreases in the market due to side effects such as respiratory failure, sedation, and gastrointestinal allergy, subsequent increase in demand for alternative pharmacy products such as intravenous ibuprofen is increasing. This, in turn, is anticipated to further fuel the market growth.
  • Several advantages associated with intravenous ibuprofen combined with rapid results and efficient drug delivery is further expected to help build the necessary brand positioning for the drug.
  • However, prevalence of few side effects associated with intravenous ibuprofen combined with lack of awareness in underdeveloped markets may hamper the market growth.

Key Market Trends

  • North America is anticipated to witness additional gains, owing to rising cases of chronic diseases such as arthritis, cardiovascular syndromes, and heart failures coupled with underlying consumer demand for better advanced therapeutics for a sustainable lifestyle.
  • Currently, Cumberland Pharmaceuticals Inc. collaborated with regional dug manufacturers and distributors across North America to widen the scope of IV intravenous ibuprofen distribution in the region.
  • Recently, Cumberland Pharmaceuticals Inc. inducted Calador to treat post-operative acute pain. It is an anti-inflammatory drug that helps with the reduction of acute pain that occurs post-surgery.
  • In November 2020, Nashville Pharmaceuticals launched IV Ibuprofen to decrease the need for opioid analgesics post surgery.

Key Benefits of the Report

  • This study presents the analytical depiction of the intravenous ibuprofen professional industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Intravenous Ibuprofen Professional Report

  • Which are the leading players active in the intravenous ibuprofen professional market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the intravenous ibuprofen professional market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is intravenous ibuprofen?
  • What is the intravenous ibuprofen professional market prediction in the future?
  • What are the current trends and predicted trends?

Intravenous Ibuprofen Professional Market Report Highlights

Aspects Details
By Type
  • Software  
  • Service
By Application
  • Pain
  • Inflammatory  
  • Fever
By Age Group
  • Pediatrics
  • Adults
By End User
  • Hospitals    
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers  
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

CSL Limited, Grifols S.A., Sandor Medicaids Pvt. Ltd., Germin MED, Laboratorios Valmorca, C.A., Harbin Gloria Pharmaceuticals Co., Ltd, Alveda Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., PT. Soho Industri Pharmasi, Al Nabeel International Ltd.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Intravenous Ibuprofen Professional Market

Global Opportunity Analysis and Industry Forecast, 2023-2032